Treatment of portal vein thrombosis in cirrhosis is associated with no survival advantage: a retrospective controlled study

Abraham Z. Cheloff,Luke J. Bonanni,Joshua D. Kirschenbaum,Naveena Luke,Jenny L. Engelman,Joshua L. Ross,Gabriel Fuligni,Patrick G. Northup
DOI: https://doi.org/10.1007/s12072-024-10734-x
IF: 9.029
2024-10-02
Hepatology International
Abstract:Portal vein thrombosis (PVT) is associated with increased mortality post-transplant, but treatment of the clot is not definitively associated with improvement in mortality. We aimed to assess the effect of anticoagulation (AC), transjugular intrahepatic portosystemic shunt (TIPS), or best supportive care only (SCO) as treatment options in patients with PVT and cirrhosis.
gastroenterology & hepatology
What problem does this paper attempt to address?